Shaheen, Senators Send Letter Urging Drug Manufacturer To Update Medication Label To Protect Women Experiencing Early-Pregnancy Miscarriage
February 03, 2023
February 03, 2023
WASHINGTON, Feb. 3 -- Sen. Jeanne Shaheen, D-New Hampshire, issued the following news release and letter:
U.S. Senator Jeanne Shaheen (D-NH) and a group of Senators sent a letter to Danco Laboratories, a manufacturer of mifepristone, urging them to submit an application to the Food and Drug Administration (FDA) to add miscarriage management to the medication's label. Currently, mifepristone's label includes medication abortion, but it can also be safely and legally used fo . . .
U.S. Senator Jeanne Shaheen (D-NH) and a group of Senators sent a letter to Danco Laboratories, a manufacturer of mifepristone, urging them to submit an application to the Food and Drug Administration (FDA) to add miscarriage management to the medication's label. Currently, mifepristone's label includes medication abortion, but it can also be safely and legally used fo . . .